Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Shri Pradeep Thakur as Non-Executive Independent Director of the Company13-05-2024
13-05-2024
Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board approves Dividend
The Board approved Final Dividend @ 20% i.e. Re. 1/- per equity share of face value Rs. 5/- each for the FY ended March 31, 2024, subject to Shareholders'' approval at ensuing AGM.13-05-2024
Aarti Pharmalabs Ltd - 543748 - Results- Financials For The Year Ended March 31, 2024
Audited Financial Results for the quarter and year ended March 31, 2024.13-05-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting13-05-2024
Aarti Pharmalabs Ltd - 543748 - Intimation Of Grant Of Options Under APL Performance Stock Option Plan 2023
Intimation of Grant of Options under APL Performance Stock Option Plan 202313-05-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference Call to discuss Company''s Q4-FY24/ FY24 Results.04-05-2024
Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Financial Results For The Quarter And Year Ended March 31, 2024 And Final Dividend For The Year Ended March 31, 2024
Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 ,inter alia, to consider and approve Audited Financial Results for the quarter ended March 31, 2024; Audited Financial Statements for the year ended March 31, 2024; Recommend Final Dividend, if any, for the year ended March 31, 2024; Approve any other business matter, if required, with the permission of Chair.04-05-2024
Aarti Pharmalabs Ltd - 543748 - Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, 2015
Certificate pursuant to Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.12-04-2024
Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201804-04-2024
Aarti Pharmalabs Ltd - 543748 - Compliance Certificate For The Financial Year Ended March 31, 2024
Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR Regulations.04-04-2024